The objective was to analyze the effect of C-type lectin domain family 4 member G (CLEC4G) on hepatocellular carcinoma (HCC) and investigate its impact on lenvatinib (Lenva) resistance as well as the underlying action pathway. Here, CLEC4G is linked to hepatocellular carcinoma.